Key Financial Data Of Group

COSMOS Pharmaceutical Corporation - Filing #7542519

Concept 2023-06-01 to
2023-08-31
As at
2023-08-31
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2022-08-31
2022-06-01 to
2022-08-31
Key financial data of group
Business results of group
Net sales
241,653,000,000 JPY
827,697,000,000 JPY
206,122,000,000 JPY
Ordinary profit (loss)
9,699,000,000 JPY
33,086,000,000 JPY
9,626,000,000 JPY
Profit (loss) attributable to owners of parent
6,508,000,000 JPY
23,797,000,000 JPY
6,481,000,000 JPY
Comprehensive income
6,507,000,000 JPY
23,832,000,000 JPY
6,483,000,000 JPY
Net assets
215,302,000,000 JPY
211,072,000,000 JPY
195,406,000,000 JPY
Total assets
435,129,000,000 JPY
420,967,000,000 JPY
373,301,000,000 JPY
Basic earnings (loss) per share
164.35
600.96
163.68
Diluted earnings per share
Equity-to-asset ratio
0.495 xbrli:pure
0.501 xbrli:pure
0.523 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.